Patents by Inventor Christa Tauer

Christa Tauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine formulations and uses thereof
    Patent number: 8795683
    Abstract: A liquid or liquid-frozen composition comprising: a modified vaccinia Ankara (MVA) virus or variant or derivative thereof and mannitol, wherein mannitol is the sole stabilization agent of the composition. The mannitol may provide a stabilizing effect at 0 to +10° C. or in a liquid-frozen composition, for example between ?10° C. and ?30° C. or between ?20° C. and ?23.5° C. The MVA may be used as a vaccine or for use in gene therapy, virotherapy, immunotherapy, or cancer therapy in a mammal, preferably a human.
    Type: Grant
    Filed: July 7, 2011
    Date of Patent: August 5, 2014
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Manfred Oberreither, Christa Tauer, Falko-Güenter Falkner
  • Method for Producing Viral Vaccines
    Publication number: 20130287811
    Abstract: The present invention provides a method for the manufacture of a preparation comprising virus antigens comprising a) inoculation of cells with infectious virus in a fluid, b) propagation of said virus in said cells, c) collecting said propagated virus, d) inactivating said collected virus, and e) treating said inactivated virus with a detergent, resulting in a preparation comprising viral antigens.
    Type: Application
    Filed: June 26, 2013
    Publication date: October 31, 2013
    Inventors: Otfried Kistner, Christa Tauer, P. Noel Barrett, Wolfgang Mundt
  • Method for producing viral vaccines
    Patent number: 8497112
    Abstract: The present invention provides a method for the manufacture of a preparation comprising virus antigens comprising a) inoculation of cells with infectious virus in a fluid, b) propagation of said virus in said cells, c) collecting said propagated virus, d) inactivating said collected virus, and e) treating said inactivated virus with a detergent, resulting in a preparation comprising viral antigens.
    Type: Grant
    Filed: August 28, 2008
    Date of Patent: July 30, 2013
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Otfried Kistner, Christa Tauer, Noel Barrett, Wolfgang Mundt
  • Method of isolation and purification of trypsin from pronase protease and use thereof
    Patent number: 8389261
    Abstract: The present invention provides methods of isolation and purification of Streptomyces griseus trypsin (SGT) from PRONASE protease mixture in a single affinity chromatography step and uses of the purified SGT.
    Type: Grant
    Filed: December 28, 2009
    Date of Patent: March 5, 2013
    Assignee: Baxter Healthcare S.A.
    Inventors: Artur Mitterer, Christa Tauer, Manfred Reiter, Wolfgang Mundt
  • Vaccine Formulations and Uses Thereof
    Publication number: 20120201847
    Abstract: A liquid or liquid-frozen composition comprising: a modified vaccinia Ankara (MVA) virus or variant or derivative thereof and mannitol, wherein mannitol is the sole stabilization agent of the composition. The mannitol may provide a stabilizing effect at 0 to +10° C. or in a liquid-frozen composition, for example between ?10° C. and ?30° C. or between ?20° C. and ?23.5° C. The MVA may be used as a vaccine or for use in gene therapy, virotherapy, immunotherapy, or cancer therapy in a mammal, preferably a human.
    Type: Application
    Filed: July 7, 2011
    Publication date: August 9, 2012
    Applicants: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE
    Inventors: Manfred Oberreither, Christa Tauer, Falko-Guenter Falkner
  • METHOD OF ISOLATION AND PURIFICATION OF TRYPSIN FROM PRONASE PROTEASE AND USE THEREOF
    Publication number: 20120003691
    Abstract: The present invention provides methods of isolation and purification of Streptomyces griseus trypsin (SGT) from PRONASE protease mixture in a single affinity chromatography step and uses of the purified SGT.
    Type: Application
    Filed: December 28, 2009
    Publication date: January 5, 2012
    Applicant: Baxter Healthcare S.A.
    Inventors: Artur Mitterer, Christa Tauer, Manfred Reiter, Wolfgang Mundt
  • Vaccine formulations and uses thereof
    Patent number: 7998488
    Abstract: A liquid or liquid-frozen composition comprising: a modified vaccinia Ankara (MVA) virus or variant or derivative thereof and mannitol, wherein mannitol is the sole stabilization agent of the composition. The mannitol may provide a stabilizing effect at 0 to +10° C. or in a liquid-frozen composition, for example between ?10° C. and ?30° C. or between ?20° C. and ?23.5° C. The MVA may be used as a vaccine or for use in gene therapy, virotherapy, immunotherapy, or cancer therapy in a mammal, preferably a human.
    Type: Grant
    Filed: November 14, 2008
    Date of Patent: August 16, 2011
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Manfred Oberreither, Christa Tauer, Falko-Guenter Falkner
  • VACCINE FORMULATIONS AND USES THEREOF
    Publication number: 20100124557
    Abstract: A liquid or liquid-frozen composition comprising: a modified vaccinia Ankara (MVA) virus or variant or derivative thereof and mannitol, wherein mannitol is the sole stabilization agent of the composition. The mannitol may provide a stabilizing effect at 0 to +10° C. or in a liquid-frozen composition, for example between ?10° C. and ?30° C. or between ?20° C. and ?23.5° C. The MVA may be used as a vaccine or for use in gene therapy, virotherapy, immunotherapy, or cancer therapy in a mammal, preferably a human.
    Type: Application
    Filed: November 14, 2008
    Publication date: May 20, 2010
    Applicants: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE S.A.
    Inventors: Manfred Oberreither, Christa Tauer, Falko-Guenter Falkner
  • Method of isolation and purification of trypsin from pronase protease and use thereof
    Patent number: 7659380
    Abstract: The present invention provides methods of isolation and purification of Streptomyces griseus trypsin (SGT) from PRONASE protease mixture in a single affinity chromatography step and uses of the purified SGT.
    Type: Grant
    Filed: April 20, 2007
    Date of Patent: February 9, 2010
    Assignee: Baxter Healthcare S.A.
    Inventors: Artur Mitterer, Christa Tauer, Manfred Reiter, Wolfgang Mundt
  • Method for Producing Viral Vaccines
    Publication number: 20090060950
    Abstract: The present invention provides a method for the manufacture of a preparation comprising virus antigens comprising a) inoculation of cells with infectious virus in a fluid, b) propagation of said virus in said cells, c) collecting said propagated virus, d) inactivating said collected virus, and e) treating said inactivated virus with a detergent, resulting in a preparation comprising viral antigens.
    Type: Application
    Filed: August 28, 2008
    Publication date: March 5, 2009
    Applicants: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE
    Inventors: Otfried Kistner, Christa Tauer, Noel Barrett, Wolfgang Mundt
  • METHOD OF PURIFICATION OF HYDROPHOBIC PROTEINS
    Publication number: 20080249014
    Abstract: The present invention relates to a method for obtaining highly purified hydrophobic proteins from cells by extraction using a buffer containing a detergent and removal of said detergent by hydroxyapatite (HA) column chromatography.
    Type: Application
    Filed: February 19, 2008
    Publication date: October 9, 2008
    Inventors: Christa Tauer, Artur Mitterer
  • Method of isolation and purification of trypsin from pronase protease and use thereof
    Publication number: 20070249015
    Abstract: The present invention provides methods of isolation and purification of Streptomyces griseus trypsin (SGT) from PRONASE protease mixture in a single affinity chromatography step and uses of the purified SGT.
    Type: Application
    Filed: April 20, 2007
    Publication date: October 25, 2007
    Applicant: Baxter Healthcare S.A.
    Inventors: Artur Mitterer, Christa Tauer, Manfred Reiter, Wolfgang Mundt
  • Use of purified trypsin for production of a biomass of cells and viral propagation
    Patent number: 7223595
    Abstract: The present invention provides methods of isolation and purification of Streptomyces griseus trypsin (SGT) from PRONASE protease mixture in a single affinity chromatography step and uses of the purified SGT.
    Type: Grant
    Filed: September 17, 2004
    Date of Patent: May 29, 2007
    Assignee: Baxter Healthcare S.A.
    Inventors: Artur Mitterer, Christa Tauer, Manfred Reiter, Wolfgang Mundt
  • Method of isolation and purification of trypsin from pronase protease and use thereof
    Publication number: 20050069534
    Abstract: The present invention provides methods of isolation and purification of Streptomyces griseus trypsin (SGT) from pronase in a single affinity chromatography step and uses of the purified SGT.
    Type: Application
    Filed: September 17, 2004
    Publication date: March 31, 2005
    Applicant: Baxter Healthcare S.A.
    Inventors: Artur Mitterer, Christa Tauer, Manfred Reiter, Wolfgang Mundt
  • Method of isolation and purification of trypsin from pronase protease and use thereof
    Patent number: 6830917
    Abstract: The present invention is directed to methods of isolation and purification of Streptomyces griseus trypsin (SGT) from PRONASE protease in a single affinity chromatography step and uses of the purified SGT.
    Type: Grant
    Filed: December 10, 2001
    Date of Patent: December 14, 2004
    Assignee: Baxter Healthcare S.A.
    Inventors: Artur Mitterer, Christa Tauer, Manfred Reiter, Wolfgang Mundt
  • Method of production of purified hepatitis a virus particles and vaccine preparation
    Patent number: 6825027
    Abstract: The present invention provides methods of purification of Hepatitis A Virus from the supernatant of an infected cell culture and production of a preparation of purified HAV antigen. The present invention is also directed to an HAV vaccine composition comprising a preparation consisting of purified mature HAV particles in an amount sufficient to induce a protective immune response in a mammal.
    Type: Grant
    Filed: December 10, 2001
    Date of Patent: November 30, 2004
    Assignee: Baxter Healthcare S.A.
    Inventors: Christa Tauer, Heidi Meyer, Artur Mitterer, Noel Barrett
  • Method of production of purified hepatitis a virus particles and vaccine preparation
    Publication number: 20030124511
    Abstract: The present invention provides methods of purification of Hepatitis A Virus from the supernatant of an infected cell culture and production of a preparation of purified HAV antigen. The present invention is also directed to an HAV vaccine composition comprising a preparation consisting of purified mature HAV particles in an amount sufficient to induce a protective immune response in a mammal.
    Type: Application
    Filed: December 10, 2001
    Publication date: July 3, 2003
    Inventors: Christa Tauer, Heidi Meyer, Artur Mitterer, Noel Barrett
  • Method of isolation and purification of trypsin from pronase and use thereof
    Publication number: 20030124650
    Abstract: The present invention provides methods of isolation and purification of Strepomyces griseus trypsin (SGT) from pronase in a single affinity chromatography step and uses of the purified SGT.
    Type: Application
    Filed: December 10, 2001
    Publication date: July 3, 2003
    Inventors: Artur Mitterer, Christa Tauer, Manfred Reiter, Wolfgang Mundt